| __timestamp | Corcept Therapeutics Incorporated | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 504755000 |
| Thursday, January 1, 2015 | 36949000 | 838526000 |
| Friday, January 1, 2016 | 45240000 | 1177697000 |
| Sunday, January 1, 2017 | 62416000 | 1320433000 |
| Monday, January 1, 2018 | 81289000 | 1556200000 |
| Tuesday, January 1, 2019 | 100359000 | 1834800000 |
| Wednesday, January 1, 2020 | 105326000 | 1346000000 |
| Friday, January 1, 2021 | 122356000 | 1824900000 |
| Saturday, January 1, 2022 | 152848000 | 2115900000 |
| Sunday, January 1, 2023 | 184259000 | 2631300000 |
| Monday, January 1, 2024 | 2954400000 |
Unleashing insights
In the competitive world of biotechnology, understanding the financial dynamics of industry leaders is crucial. Over the past decade, Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Regeneron's SG&A expenses surged by over 400%, peaking at approximately $2.63 billion in 2023. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Corcept's expenses grew by a more modest 428%, reaching around $184 million in the same year. This disparity highlights Regeneron's larger scale and broader market reach. The data underscores the strategic financial decisions each company has made, with Regeneron focusing on scaling operations and Corcept maintaining a leaner approach. These insights provide a window into the operational strategies that drive success in the biotech sector.
Cost Management Insights: SG&A Expenses for Eli Lilly and Company and Corcept Therapeutics Incorporated
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Summit Therapeutics Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Regeneron Pharmaceuticals, Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Regeneron Pharmaceuticals, Inc. and Cytokinetics, Incorporated
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Regeneron Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Biogen Inc. and Corcept Therapeutics Incorporated
Breaking Down SG&A Expenses: Corcept Therapeutics Incorporated vs Arrowhead Pharmaceuticals, Inc.